healthFDA Approves AstraZeneca's FluMist Quadrivalent as First At-Home Self-Administered Flu Vaccine
The U.S. Food and Drug Administration has approved FluMist Quadrivalent for self- or caregiver-administration, establishing the first influenza vaccine in the United States that does not require an in-person healthcare provider visit.